LIP
CTXR icon

Lighthouse Investment Partners’s Citius Pharmaceuticals CTXR Stock Holding History

Lighthouse Investment Partners’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,445
Closed -$42.3K – 312
2023
Q1 		$42.3K Buy
+1,445
New +$41.7K ﹤0.01% 254

Other funds holding CTXR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lighthouse Investment Partners's CTXR Position: Q2 2023 in Review

Lighthouse Investment Partners sold out of Citius Pharmaceuticals (CTXR) in Q2 2023, closing a stake of 1,445 shares — an estimated $42.3K sold.

Lighthouse Investment Partners first reported a position in CTXR in Q1 2023 and held it in 1 quarter. The position peaked at $42.3K in Q1 2023. 74 funds tracked by Wall St. Rank hold CTXR as of Q2 2023.

  • Lighthouse Investment Partners reported no remaining Citius Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Lighthouse Investment Partners sold 1,445 Citius Pharmaceuticals shares in Q2 2023, an estimated $42.3K.
  • Lighthouse Investment Partners first reported a position in Citius Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Lighthouse Investment Partners's Citius Pharmaceuticals position peaked at $42.3K in Q1 2023.
  • 74 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2023.

Based on Lighthouse Investment Partners's 13F filing for Q2 2023, filed 14 Aug 2023.